Marzena Jaskiewicz-Welnicka
Gdansk, PM, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Activation of epithelial-mesenchymal transition process during breast cancer progression - the impact of molecular subtype and stromal composition.
Journal: Acta biochimica Polonica
Published: June 01, 2021
Clinical and Biological Significance of ESR1 Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer Patients.
Journal: International journal of molecular sciences
Published: February 06, 2019
Aggressive Phenotype of Cells Disseminated via Hematogenous and Lymphatic Route in Breast Cancer Patients.
Journal: Translational oncology
Published: January 16, 2018
Cardiac safety, efficacy, and correlation of serial serum HER2-extracellular domain shed antigen measurement with the outcome of the combined trastuzumab plus CMF in women with HER2-positive metastatic breast cancer: results from the EORTC 10995 phase II study.
Journal: Breast cancer research and treatment
Published: March 09, 2017
CD99 correlates with low cyclin D1, high topoisomerase 2 status and triple negative molecular phenotype but is prognostically irrelevant in breast carcinoma.
Journal: Polish journal of pathology : official journal of the Polish Society of Pathologists
Published: December 01, 2015
Stromal expression of ALDH1 in human breast carcinomas indicates reduced tumor progression.
Journal: Oncotarget
Published: February 24, 2015
Epithelial-mesenchymal transition markers in lymph node metastases and primary breast tumors - relation to dissemination and proliferation.
Journal: American journal of translational research
Published: September 04, 2014
Mesenchymal phenotype of CTC-enriched blood fraction and lymph node metastasis formation potential.
Journal: PloS one
Published: November 18, 2013
Heterogeneity of mesenchymal markers expression-molecular profiles of cancer cells disseminated by lymphatic and hematogenous routes in breast cancer.
Journal: Cancers
Published: August 29, 2013
Are bilateral breast cancers different from breast cancers coexisting with ovarian cancer? An immunohistochemical analysis aimed at intrinsic tumor phenotype.
Journal: Breast (Edinburgh, Scotland)
Published: December 05, 2012
Last Updated: 09/26/2026